Skip to main content

Table 2 Human studies discussed in the present review

From: Are ketogenic diets promising for Alzheimer’s disease? A translational review

Study 1st author (ref)

Population

Mean age (SD)

Intervention

N

Design

FU

Outcomes

Positive outcomes (intervention group)

Plasma KB levels

Nutritional changes

Side effects

Fortier [28]

MCI

75.4 (6.6)

KS vs placebo

52

RCT

26

MMSE, MoCa, brain PET imaging

Imaging (but not cognition)

Yes

Stable weight

No adverse effect

Ota [29]

Mild-moderate AD

73.4 (6.0)

KS vs control

20

RCT

12

Memory, executive function

Cognition

Yes

Unassessed

Unassessed

Torosyan [30]

Mild-moderate AD

79.9 (9.2)

KS vs control

14

RCT

6

Brain PET imaging

Imaging

No

Unassessed

Unassessed

Taylor [31]

MCI or AD dementia

73.1 (9.0)

KS

15

No control group

12

ADAS-cog, MMSE, feasibility

Cognition

Yes

Stable weight, cholesterol, glucose

Unassessed

Abe [32]

Nursing home residents

86.6 (4.8)

KS + vitD + leucine vs vitD leucine vs control

38

RCT

12

MMSE

Cognition

No

Improved muscle mass and function

Unassessed

Ota [33]

60+ adults no dementia

66.1 (2.9)

KS vs placebo

19

Crossover, RC

0

Memory, executive function

Cognition

Yes

Unassessed

Unassessed

Ohnuma [34]

Mild moderate AD

63.9 (8.5)

KS vs control

22

RCT

12

MMSE

None

Yes

Unassessed

Unassessed

Rebello [35]

MCI

Not available

KS vs control

6

RCT

24

ADAS-cog, TMT, DST

Inconclusive

Yes

Stable weight

No adverse effect

Krikorian [36]

MCI

70.1 (6.2)

KD vs CD

23

RCT

6

Executive function, memory

Cognition

No (urinary tests)

Weight loss

No adverse effect

Henderson [37]

Mild-moderate AD

76.9 (7.9)

KS vs placebo

152

RCT

12

ADAS-cog, ADCS-CGIC

Cognition

Yes

Unassessed

Frequent GI symptoms

Reger [38]

MCI or AD dementia

74.7 (6.7)

KS vs placebo

20

Crossover, RC

0

ADAS-cog, MMSE, word recall, Stroop

Cognition

Yes

Unassessed

Unassessed

  1. AD Alzheimer’s disease, ADAS-cog Alzheimer Disease Assessment Scale, ADCS-CGIC Alzheimer’s Disease Cooperative Study Clinical Global Impression of Change, CD control diet, DST Digit Symbol Test, FU follow-up duration, GI gastrointestinal, KB ketone bodies, KD ketogenic diet, KS ketone supplementation, MCI mild cognitive impairment, MoCA Montreal Cognitive Assessment, N number, MMSE Mini-Mental Status Examination, PET positron emission tomography, RCT randomized controlled trial, TMT Trail Making Test, vitD vitamin D